Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Seres Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 148 | 1 | 131 | −16 |
| Shares | 77.2M | 36 | 75.5M | −1.72M (−2.2%) |
| Value | $642.8M | $0 | $537.2M | −$105.6M (−16.4%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Seres Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dimensional Fund Advisors LP | 468,311 | $3.33M | 0.00% |
| Amalgamated Financial Corp. | 11,332 | $81.0K | 0.00% |
| Blueshift Asset Management, LLC | 10,294 | $73.0K | 0.01% |
| Allspring Global Investments Holdings, LLC | 7,346 | $52.0K | 0.00% |
| Kayne Anderson Rudnick Investment Management LLC | 247 | $2.00K | 0.00% |
| CWM, LLC | 225 | $2.00K | 0.00% |
| Capital Advisors, Ltd. LLC | 11 | $0 | 0.00% |
Sold out (23)
Institutions that held Seres Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Toronto Dominion Bank | 139,042 | $1.16M |
| Marshall Wace, LLP | 123,005 | $1.02M |
| Gyon Technologies Capital Management, LP | 54,103 | $451.0K |
| Corton Capital Inc. | 34,901 | $291.0K |
| Virtu Financial LLC | 34,422 | $287.0K |
| Manteio Capital LLC | 29,985 | $250.0K |
| Erste Asset Management GmbH | 27,000 | $235.4K |
| Quantbot Technologies LP | 28,192 | $234.0K |
| Jump Financial, LLC | 26,488 | $221.0K |
| Dynamic Technology Lab Private Ltd | 21,602 | $180.0K |
| Quantamental Technologies LLC | 21,480 | $179.0K |
| Squarepoint Ops LLC | 19,363 | $161.0K |
| Fox Run Management, L.L.C. | 13,578 | $113.0K |
| Delphia (USA) Inc. | 13,531 | $113.0K |
| SG Americas Securities, LLC | 12,018 | $100.0K |
| XTX Topco Ltd | 11,588 | $97.0K |
| Alpine Global Management, LLC | 10,575 | $88.0K |
| Gotham Asset Management, LLC | 10,141 | $84.0K |
| Simplex Trading, LLC | 8,818 | $73.0K |
| Lazard Asset Management LLC | 8,276 | $68.0K |
| Retirement Planning Co of New England, Inc. | 950 | $7.00K |
| Spire Wealth Management | 150 | $1.00K |
| Dark Forest Capital Management LP | 24 | $0 |
Not filed for Q1 2022 yet (1)
Institutions that held Seres Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Bell Investment Advisors, Inc | 36 | $0 |